Stock Price
23.76
Daily Change
1.18 5.23%
Monthly
-14.41%
Yearly
5.74%
Q1 Forecast
23.84

Celldex Therapeutics reported $54.2M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
Amgen USD 1.79B 128M Dec/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Celldex Therapeutics USD 54.2M 8.94M Jun/2025
Glaxosmithkline GBP 3.01B 853.01M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025